Probiotics
  EFFCA views
  Links
  Contact us
 
   
 

Probiotics: the basis for the substantiation of gut and immune health
Scientific workshop organised by EFFCA and LABIP on 24 March 2010 in Brussels

A debate among the scientific community on the data required to establish a probiotic health benefit claim is currently taking place.  The objective of the workshop was to provide a “practical guide” for those involved in the scientific substantiation of probiotic health claims used in the EU.
 This workshop has confirmed that, even though there is not always consensus on the relation of immune parameters to general health or how to maintain the normal situation in the intestinal tract, there is a large number of excellent human studies that warrant substantiating specific gut or immune health claims for probiotics. Therefore, we must secure that these scientific findings are acknowledged in the EU regulations..

 

Download the program

Executive Summary

 

 

Video Highlights

Introduction by Mr Knud Vindfeldt, President of EFFCA

view larger picture (new window)

   
  Introduction by Dr Jan Sikkema

view larger picture (new window)
   
 

Current state of play on what can be found in the literature today

Pr Ger Rijkers

  Part 1

view larger picture (new window)  
Part 2

view larger picture (new window)  
  Pr Lorenzo Morelli
  Part 1

view larger picture (new window)  
Part 2
 
view larger picture (new window)  
  Pr Robert-Jan Brummer
  Part 1

view larger picture (new window)  
Part 2

view larger picture (new window)
   
  Q&A Session
  Part 1

view larger picture (new window)  
Part 2

view larger picture (new window)
  Part 3

view larger picture (new window)
   
 

Example of specific immune health benefits (end points, biomarkers)

Pr Ger Rijkers

  Part 1

view larger picture (new window)  
Part 2

view larger picture (new window)
  Part 3

view larger picture (new window)
 
  Pr Eric Claassen
  Part 1

view larger picture (new window)  
Part 2

view larger picture (new window)
  Q&A Session
  Part 1

view larger picture (new window)
Part 2

view larger picture (new window)
  Part 3

view larger picture (new window)
Part 4

view larger picture (new window)
   
 

How to demonstrate beneficial effects in healthy populations?

Pr Lorenzo Morelli

  Part 1

view larger picture (new window)
Part 2

view larger picture (new window)
  Part 3

view larger picture (new window)
Part 4

view larger picture (new window)
   
  Conclusion by Mr Esben Laulund, Chairman of the steering Committee of LABIP
   
view larger picture (new window)
 

 

 
 
Members only
 

 
EFFCA © 2010